Wage pressures in pockets of corporate America suggest labor costs could be a bigger headwind for U.S. companies in 2016.
Ventas said it would buy privately held hospital chain Ardent Medical Services for $1.75 billion in cash.
Cramer spent Wednesday sifting through the Fed statement and the comments made by Fed chief Janet Yellen. They're quite telling.
Despite overseas unrest, Cramer thinks the backdrop for stocks is relatively bullish. Here's what's on his calendar.
As the global population ages, some see investment opportunities in somewhat ghoulish bets the rates of cancer and other illnesses will rise.
Some of the names on the move ahead of the open.
Real estate investment trusts are handily beating the S&P 500 this year, and there are five big trends that should continue to favor REITs.
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.
Many companies continue to pick up the tab for CEOs' spouses who accompany them on business trips. USA Today reports.
Even when lawmakers play games with the full faith and credit of the United States government, Cramer can find opportunity.
In a note to clients, Goldman Sachs strategist David J. Kostin on Wednesday identified what he thinks are the top 40 most undervalued stocks.
Conventional wisdom would suggest it’s time to get out of the market about now. But this market is anything but conventional.
Debra Cafaro, CEO of Ventas, chats with Cramer about what's next for her company.
Whatever the Supreme Court decides, health care REITs would see a modest impact, depending on how heavily invested they are in the different health-real estate subsets, analysts say.
A new research report from Goldman Sachs finds that trading in exchange-traded funds does impact individual stocks, but not equally.
What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.
The "Mad Money" host also discusses Goldman Sachs and some strong financials from Canada.
Stocks closed February on a strong note, leading to three consecutive months of gains, as all the major indices gained in the final minutes of trading. J&J and Verizon rose, while Intel fell.
Stocks traded mixed Monday, as blue chips advanced and small stocks slumped, yet the market was still on track to start the year with two straight months of gains. Johnson & Johnson and HP gained, while Intel fell.
Based on the number of M&A deals and other financial indicators, the global market is recovering—and it’s here to stay—Mark Shafir, head of global mergers and acquisitions at Citigroup, told CNBC Monday.